Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CG Oncology Inc. Common s...

    NASDAQ: CGON · Real-Time Price · USD
    25.96
    -0.11 (-0.42%)
    At close: Jun 27, 2025, 3:59 PM
    25.95
    -0.06%
    After-hours: Jun 27, 2025, 05:12 PM EDT

    CG Oncology Common stock Statistics

    Share Statistics

    CG Oncology Common stock has 76.23M shares outstanding. The number of shares has increased by 15.29% in one year.

    Shares Outstanding

    n/a
    		 76.23M

    Shares Change (YoY)

    n/a
    		 15.29%

    Shares Change (QoQ)

    n/a
    		 0.92%

    Owned by Institutions (%)

    n/a
    		 95.76%

    Shares Floating

    n/a
    		 44.88M

    Failed to Deliver (FTD) Shares

    n/a
    		 21,000

    FTD / Avg. Volume

    n/a
    		 1.51%

    Short Selling Information

    The latest short interest is 12.34M, so 16.19% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.34M

    Short % of Shares Out

    n/a
    		 16.19%

    Short % of Float

    n/a
    		 17.14%

    Short Ratio (days to cover)

    n/a
    		 13.65

    Valuation Ratios

    The PE ratio is -20.36 and the forward PE ratio is -14.77. CG Oncology Common stock's PEG ratio is -0.22.

    PE Ratio

    n/a
    		 -20.36

    Forward PE

    n/a
    		 -14.77

    PS Ratio

    n/a
    		 1573.67

    Forward PS

    n/a
    		 2.5

    PB Ratio

    n/a
    		 2.44

    P/FCF Ratio

    n/a
    		 -22.7

    PEG Ratio

    n/a
    		 -0.22
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for CG Oncology Common stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 35.3, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 35.3

    Quick Ratio

    n/a
    		 35.3

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $10,079.65

    Profits Per Employee

    n/a
    		 $-779,106.19

    Employee Count

    n/a
    		 113

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -13.82% in the last 52 weeks. The beta is 0.86, so CG Oncology Common stock's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.86

    52-Week Price Change

    n/a
    		 -13.82%

    50-Day Moving Average

    n/a
    		 25.09

    200-Day Moving Average

    n/a
    		 29.57

    Relative Strength Index (RSI)

    n/a
    		 51.79

    Average Volume (20 Days)

    n/a
    		 1,392,095

    Income Statement

    In the last 12 months, CG Oncology Common stock had revenue of 1.14M and earned -88.04M in profits. Earnings per share was -1.41.

    Revenue

    n/a
    		 1.14M

    Gross Profit

    n/a
    		 1.14M

    Operating Income

    n/a
    		 -114.67M

    Net Income

    n/a
    		 -88.04M

    EBITDA

    n/a
    		 -114.63M

    EBIT

    n/a
    		 -114.67M

    Earnings Per Share (EPS)

    n/a
    		 -1.41
    Full Income Statement

    Balance Sheet

    The company has 257.07M in cash and 238K in debt, giving a net cash position of 256.83M.

    Cash & Cash Equivalents

    n/a
    		 257.07M

    Total Debt

    n/a
    		 238K

    Net Cash

    n/a
    		 256.83M

    Retained Earnings

    n/a
    		 -217.98M

    Total Assets

    n/a
    		 728.18M

    Working Capital

    n/a
    		 678.55M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -78.71M and capital expenditures -234K, giving a free cash flow of -78.95M.

    Operating Cash Flow

    n/a
    		 -78.71M

    Capital Expenditures

    n/a
    		 -234K

    Free Cash Flow

    n/a
    		 -78.95M

    FCF Per Share

    n/a
    		 -1.26
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -10067.25% and -7729.5%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -10067.25%

    Pretax Margin

    n/a
    		 -7729.5%

    Profit Margin

    n/a
    		 -7729.5%

    EBITDA Margin

    n/a
    		 -10064.44%

    EBIT Margin

    n/a
    		 -10067.25%

    FCF Margin

    n/a
    		 -6931.26%

    Dividends & Yields

    CGON does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CGON is $65, which is 149.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $65

    Price Target Difference

    n/a
    		 149.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 49.39

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist